title: Targeting FGFR, ephrins, Mer, MET, and PDGFR-α in non-small cell lung cancer.
authors: Stanford University/Stanford Cancer Center, Stanford, California, USA.
authors: Jonathan W
authors: JW
authors: Riess
authors: Joel W
authors: JW
authors: Neal
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000378:metabolism; D002986:Clinical Trials as Topic; D036342:Ephrins / Q000037:antagonists & inhibitors* / Q000378:metabolism; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D011518:Proto-Oncogene Proteins / Q000037:antagonists & inhibitors* / Q000378:metabolism; D019859:Proto-Oncogene Proteins c-met / Q000037:antagonists & inhibitors* / Q000378:metabolism; D020794:Receptor Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D051496:Receptor, Fibroblast Growth Factor, Type 1 / Q000037:antagonists & inhibitors* / Q000378:metabolism; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000037:antagonists & inhibitors* / Q000378:metabolism; D000076202:c-Mer Tyrosine Kinase
chemical_list: D000970:Antineoplastic Agents; D036342:Ephrins; D011518:Proto-Oncogene Proteins; C496348:FGFR1 protein, human; C097072:MERTK protein, human; C491743:MET protein, human; D019859:Proto-Oncogene Proteins c-met; D020794:Receptor Protein-Tyrosine Kinases; D051496:Receptor, Fibroblast Growth Factor, Type 1; D020796:Receptor, Platelet-Derived Growth Factor alpha; D000076202:c-Mer Tyrosine Kinase